Proceeding with remaining steps, including the SPAC merger shareholders’ meeting
Graphic related to Cube Bio’s planned Nasdaq listing. Source: Cube Bio
Cube Bio’s efforts to list on the Nasdaq in the United States have moved to the next stage.
Cube Bio announced on the 2nd that the registration statement (Form F-4) it filed with the U.S. Securities and Exchange Commission (SEC) became effective on September 30, local time. Form F-4 is a document submitted by foreign companies when issuing securities in the United States through mergers and similar transactions.
Accordingly, Cube Bio will proceed with the remaining procedures, including putting the merger proposal with the special purpose acquisition company (SPAC) Mountain Crest Acquisition Corp. V to a shareholders’ meeting.
The market the company is targeting is the Nasdaq Global Market. Upon listing, it plans to use “KUBE” as its ticker symbol.
The company intends to strengthen its existing business after listing and expand its business scope by considering mergers and acquisitions (M&A). It did not disclose specific M&A targets or timelines.
A company representative said, “While proceeding with the remaining listing procedures, we will also flesh out our growth strategies, including M&A, following the listing.”
Choi Yong-seok
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
